Wells Fargo’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $244K | Sell |
79,445
-54,375
| -41% | -$236K | ﹤0.01% | 4593 |
|
|
2025
Q4 | $476K | Buy |
133,820
+19,950
| +18% | +$122K | ﹤0.01% | 4535 |
|
|
2025
Q3 | $1.01M | Buy |
113,870
+10,576
| +10% | +$107K | ﹤0.01% | 3810 |
|
|
2025
Q2 | $952K | Buy |
103,294
+3,823
| +4% | +$32.6K | ﹤0.01% | 3717 |
|
|
2025
Q1 | $853K | Sell |
99,471
-2,002
| -2% | -$18.9K | ﹤0.01% | 3755 |
|
|
2024
Q4 | $1.09M | Sell |
101,473
-29,321
| -22% | -$226K | ﹤0.01% | 3648 |
|
|
2024
Q3 | $743K | Buy |
130,794
+46,431
| +55% | +$268K | ﹤0.01% | 3740 |
|
|
2024
Q2 | $356K | Buy |
84,363
+11,437
| +16% | +$46.3K | ﹤0.01% | 4133 |
|
|
2024
Q1 | $371K | Buy |
72,926
+4,780
| +7% | +$26.9K | ﹤0.01% | 4080 |
|
|
2023
Q4 | $634K | Sell |
68,146
-43,535
| -39% | -$300K | ﹤0.01% | 3714 |
|
|
2023
Q3 | $732K | Sell |
111,681
-45,009
| -29% | -$358K | ﹤0.01% | 3536 |
|
|
2023
Q2 | $1.27M | Sell |
156,690
-2,888
| -2% | -$24.7K | ﹤0.01% | 3283 |
|
|
2023
Q1 | $1.37M | Buy |
159,578
+69,415
| +77% | +$693K | ﹤0.01% | 3157 |
|
|
2022
Q4 | $835K | Buy |
90,163
+53,207
| +144% | +$568K | ﹤0.01% | 3352 |
|
|
2022
Q3 | $382K | Sell |
36,956
-44
| -0.1% | -$464 | ﹤0.01% | 3862 |
|
|
2022
Q2 | $370K | Sell |
37,000
-71,049
| -66% | -$673K | ﹤0.01% | 3922 |
|
|
2022
Q1 | $1.33M | Sell |
108,049
-19,606
| -15% | -$241K | ﹤0.01% | 3652 |
|
|
2021
Q4 | $2.21M | Buy |
127,655
+29,915
| +31% | +$568K | ﹤0.01% | 3400 |
|
|
2021
Q3 | $1.75M | Buy |
97,740
+6,839
| +8% | +$136K | ﹤0.01% | 3779 |
|
|
2021
Q2 | $2.08M | Buy |
90,901
+33,617
| +59% | +$498K | ﹤0.01% | 3660 |
|
|
2021
Q1 | $856K | Sell |
57,284
-88,709
| -61% | -$969K | ﹤0.01% | 4358 |
|
|
2020
Q4 | $788K | Sell |
145,993
-5,403
| -4% | -$28.5K | ﹤0.01% | 4198 |
|
|
2020
Q3 | $689K | Sell |
151,396
-7,250
| -5% | -$31.2K | ﹤0.01% | 4123 |
|
|
2020
Q2 | $780K | Buy |
158,646
+35,220
| +29% | +$133K | ﹤0.01% | 4009 |
|
|
2020
Q1 | $389K | Buy |
123,426
+34,485
| +39% | +$120K | ﹤0.01% | 4226 |
|
|
2019
Q4 | $231K | Buy |
88,941
+13,149
| +17% | +$34.5K | ﹤0.01% | 4865 |
|
|
2019
Q3 | $239K | Buy |
75,792
+19,892
| +36% | +$57.4K | ﹤0.01% | 4854 |
|
|
2019
Q2 | $188K | Sell |
55,900
-3,667
| -6% | -$11.4K | ﹤0.01% | 5008 |
|
|
2019
Q1 | $181K | Buy |
59,567
+5,428
| +10% | +$13K | ﹤0.01% | 4873 |
|
|
2018
Q4 | $84K | Buy |
54,139
+6,377
| +13% | +$14.5K | ﹤0.01% | 5362 |
|
|
2018
Q3 | $131K | Sell |
47,762
-1,580
| -3% | -$4.46K | ﹤0.01% | 5225 |
|
|
2018
Q2 | $129K | Sell |
49,342
-20,663
| -30% | -$57.7K | ﹤0.01% | 5256 |
|
|
2018
Q1 | $193K | Sell |
70,005
-5,812
| -8% | -$16.4K | ﹤0.01% | 5001 |
|
|
2017
Q4 | $244K | Buy |
75,817
+18,944
| +33% | +$74.6K | ﹤0.01% | 4861 |
|
|
2017
Q3 | $236K | Buy |
56,873
+16,488
| +41% | +$73.3K | ﹤0.01% | 4837 |
|
|
2017
Q2 | $215K | Buy |
40,385
+4,347
| +12% | +$25.1K | ﹤0.01% | 4736 |
|
|
2017
Q1 | $207K | Hold |
36,038
| – | – | ﹤0.01% | 4790 |
|
|
2016
Q4 | $143K | Buy |
36,038
+9,702
| +37% | +$34.6K | ﹤0.01% | 4940 |
|
|
2016
Q3 | $95K | Buy |
26,336
+25,367
| +2,618% | +$107K | ﹤0.01% | 4941 |
|
|
2016
Q2 | $6K | Sell |
969
-2,763
| -74% | -$13.3K | ﹤0.01% | 5775 |
|
|
2016
Q1 | $18K | Sell |
3,732
-8,372
| -69% | -$36.8K | ﹤0.01% | 5538 |
|
|
2015
Q4 | $68K | Buy |
+12,104
| New | +$86.1K | ﹤0.01% | 5152 |
|
Other funds holding AVXL
VCM
SF
VPM